The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Path: Eosinophilic pneumonia (subacute or acute) (see also Ic)
Publications
Ferrusquía J, Pérez-Martínez I, Gómez de la Torre R, Fernández-Almira ML, de Francisco R, Rodrigo L, Riestra S
Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.
World journal of gastroenterology 2015 Apr 07;21;4069-77 — 2015 Apr 07 — 4069-77
[Organizing pneumonia during treatment with mesalazine].
Revue des maladies respiratoires 2014 Jan;31;70-7 — 2014 Jan — 70-7
Acute eosinophilic pneumonia related to a mesalazine suppository.
Asia Pacific allergy 2013 Apr;3;136-9 — 2013 Apr — 136-9